Accellta Overview

  • Founded
  • 2012
  • Status
  • Private
  • Employees
  • 14
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $4M
Latest Deal Amount
  • Investors
  • 4

Accellta General Information


Developer of stem cell culture technologies designed to offers a range of revolutionary solutions for better affordability and quality of stem cell culture. The company's technologies offer custom-made solutions for mass production of high-quality human embryonic and induced pluripotent stem cells, progenitors, and differentiated cells for drug discovery, regenerative medicine, and research, thereby enabling clinicians to provide a cost-effective genetic manipulation of the cells with enhanced uniformity and purity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Primary Office
  • 1 Rose Avenue
  • Malat Building, Technion City
  • Haifa 3200004
  • Israel
+972 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Accellta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 26-Oct-2014 $4M 000 00.000 Completed Generating Revenue
2. Grant 08-Jan-2014 000.00 Completed Generating Revenue
1. Seed Round 01-Nov-2012 Completed Startup
To view Accellta’s complete valuation and funding history, request access »

Accellta Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Accellta’s complete cap table history, request access »

Accellta Executive Team (7)

Name Title Board Seat Contact Info
Michal Amit Ph.D Co-Founder, Chief Executive Officer & Chief Technology Officer
Yael Garfinkel Chief Financial Officer
Gadi Lipiner Ph.D Manager, Business Development
Patrick Zhang Chairman
You’re viewing 4 of 7 executive team members. Get the full list »

Accellta Board Members (7)

Name Representing Role Since
Michael Schickler Ph.D Self Board Member 000 0000
Patrick Zhang Self Chairman 000 0000
Peretz Lavie Accellta Board Member 000 0000
Rona Samler Accellta Board Member 000 0000
Yigal Koltin Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Accellta Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Accellta Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizons Ventures Venture Capital Minority 000 0000 000000 0
Rambam Health Care Campus Corporation Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Alfred Mann Institute at the Technion Accelerator/Incubator Minority 000 0000 000000 0
To view Accellta’s complete investors history, request access »